Tamoxifen might be effective in the treatment of Leishmania amazonensis infections

Researchers from the University of São Paulo, Brazil, have shown the efficacy of an alternative drug against Leishmania amazonensis, one of the species that causes cutaneous leishmaniasis in South America. Details, published June 11th in the open-access journal PLoS Neglected Tropical Diseases, explain how tamoxifen - a medication widely used in the treatment and prevention of breast cancer - fights the parasitic disease in experimentally infected mice.

Read the whole article on Physorg

More from Physorg